Literature DB >> 27752973

TiO2-containing and ZnO-containing borosilicate glass-a novel thin glass with exceptional antibiofilm performances to prevent microfouling.

Mareike Klinger-Strobel1,2, Oliwia Makarewicz3,4, Mathias W Pletz3,4, Andreas Stallmach4,5, Christian Lautenschläger4,5.   

Abstract

Biofilm formation, also known as microfouling, on indwelling medical devices such as catheters or prosthetic joints causes difficult to treat and recurrent infections. It is also the initial step for biocorrosion of surfaces in aquatic environment. An efficient prevention of microfouling is preferable but the development of antibiofilm surfaces is enormously challenging. Therefore, soda-lime, aluminosilicate, and three borosilicate glasses with different TiO2 and ZnO compositions were investigated on their feasibility to prevent biofilm formation by standardized in vitro biofilm assays using different pathogenic bacteria. Furthermore, the biocompatibility of these glasses was evaluated using eukaryotic cell lines end erythrocytes. Only two borosilicate glasses, containing TiO2 and ZnO, showed an increased antibiofilm performance inhibiting biofilm adhesion and formation. The biofilm thickness and area were significantly reduced by over 90 % and characterized by diffuse structures. All tested glass types showed neither cytotoxicity nor hemotoxicity. Therefore, the antibiofilm borosilicate-thin glasses are qualified for surface coatings where biofilms are not desirable such as on medical devices.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27752973     DOI: 10.1007/s10856-016-5792-4

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  27 in total

Review 1.  Biofilms as complex differentiated communities.

Authors:  P Stoodley; K Sauer; D G Davies; J W Costerton
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

2.  Poly(2-ethyl-2-oxazoline) as alternative for the stealth polymer poly(ethylene glycol): comparison of in vitro cytotoxicity and hemocompatibility.

Authors:  Marius Bauer; Christian Lautenschlaeger; Kristian Kempe; Lutz Tauhardt; Ulrich S Schubert; Dagmar Fischer
Journal:  Macromol Biosci       Date:  2012-05-30       Impact factor: 4.979

3.  Biofilms in an urban water distribution system: measurement of biofilm biomass, pathogens and pathogen persistence within the Greater Stockholm Area, Sweden.

Authors:  J Långmark; M V Storey; N J Ashbolt; T A Stenström
Journal:  Water Sci Technol       Date:  2005       Impact factor: 1.915

Review 4.  Recent developments in superhydrophobic surfaces and their relevance to marine fouling: a review.

Authors:  Jan Genzer; Kirill Efimenko
Journal:  Biofouling       Date:  2006       Impact factor: 3.209

5.  Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms.

Authors:  Mette Burmølle; Jeremy S Webb; Dhana Rao; Lars H Hansen; Søren J Sørensen; Staffan Kjelleberg
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

Review 6.  Medical significance and management of staphylococcal biofilm.

Authors:  Astha Agarwal; Kaleshwar Prasad Singh; Amita Jain
Journal:  FEMS Immunol Med Microbiol       Date:  2009-08-19

7.  In vitro and in vivo antimicrobial activity of covalently coupled quaternary ammonium silane coatings on silicone rubber.

Authors:  Bart Gottenbos; Henny C van der Mei; Flip Klatter; Paul Nieuwenhuis; Henk J Busscher
Journal:  Biomaterials       Date:  2002-03       Impact factor: 12.479

Review 8.  Reducing implant-related infections: active release strategies.

Authors:  Evan M Hetrick; Mark H Schoenfisch
Journal:  Chem Soc Rev       Date:  2006-05-05       Impact factor: 54.564

9.  Efficacy of silver-coated fabric to prevent bacterial colonization and subsequent device-based biofilm formation.

Authors:  U Klueh; V Wagner; S Kelly; A Johnson; J D Bryers
Journal:  J Biomed Mater Res       Date:  2000

10.  Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa: a first in vivo study in human patients.

Authors:  Carsten Schmidt; Christian Lautenschlaeger; Eva-Maria Collnot; Michael Schumann; Christian Bojarski; Jörg-Dieter Schulzke; Claus-Michael Lehr; Andreas Stallmach
Journal:  J Control Release       Date:  2012-11-02       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.